title: Uptake of 3,3',5,5'-tetraiodothyroacetic acid and 3,3',5'-triiodothyronine in cultured rat anterior pituitary cells and their effects on thyrotropin secretion.
abstract: We compared the uptake, metabolism, and biological effects of tetraiodothyroacetic acid (Tetrac) and rT3 in anterior pituitary cells with those of T4 and T3. Cells were isolated from adult male Wistar rats and cultured for 3 days in medium with 10% fetal calf serum. Uptake was measured at 37 C in medium with 0.1% BSA for [125I]Tetrac (200,000 cpm; 240 pM) and [125I]T4 (100,000 cpm; 175 pM) or with 0.5% BSA for [125I]rT3 (100,000 cpm; 250 pM) and [125I]T3 (50,000 cpm; 50 pM). The free fraction of Tetrac was 1% that of T4 (in medium with 0.1 and with 0.5% BSA), and the free fraction of rT3 was half that of T3. Uptake of the four tracers increased sharply up to 1 h of incubation and then leveled off. Expressed as femtomoles per pM free hormone, uptake at equilibrium was 1.16 +/- 0.16 (n = 6) for Tetrac, 0.15 +/- 0.01 (n = 6) for T4, 0.023 +/- 0.003 (n = 6) for rT3, and 0.21 +/- 0.02 (n = 6) for T3. Cell-associated radioactivity after incubation for 24 h with [125I]Tetrac was represented for 15% by [125I]Triac; after incubation with [125I]T4 for 15-20% by [125I]T3, after incubation with [125I]rT3 for 6% by [125I]3,3'-T2, while [125I]T3 was still for 98% [125I]T3. Exposure of cells for 2 h to 100 nM TRH stimulated TSH release by 90-135%. Tetrac was effective in reducing this response at a free concentration of 0.05 pM, but rT3 was effective only at a free concentration of 16 nM. A free Tetrac concentration of 5 pM was equally effective as 50 pM free T4 in reducing the TSH response to TRH. In human serum, Tetrac was exclusively bound to T4-binding prealbumin. The free Tetrac fraction was 0.001% in control subjects and rose 2- to 12-fold in patients with nonthyroidal illness. As uptake of [125I]Tetrac in the pituitary was higher than that of T4 and T3, and it was more potent than T4 in reducing TSH release, Tetrac may be of potential significance for the regulation of TSH secretion in vivo.
authors.affiliation: Department of Internal Medicine, Erasmus University Medical School, Rotterdam, The Netherlands.
authors.forename: M E
authors.initials: ME
authors.lastname: Everts
authors.forename: T J
authors.initials: TJ
authors.lastname: Visser
authors.forename: E P
authors.initials: EP
authors.lastname: Moerings
authors.forename: A M
authors.initials: AM
authors.lastname: Tempelaars
authors.forename: H
authors.initials: H
authors.lastname: van Toor
authors.forename: R
authors.initials: R
authors.lastname: Docter
authors.forename: M
authors.initials: M
authors.lastname: de Jong
authors.forename: E P
authors.initials: EP
authors.lastname: Krenning
authors.forename: G
authors.initials: G
authors.lastname: Hennemann
mesh_terms: D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D002478:Cells, Cultured; D008297:Male; D010903:Pituitary Gland, Anterior / Q000166:cytology / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D011994:Recombinant Proteins / Q000494:pharmacology; D013972:Thyrotropin / Q000378:metabolism*; D013974:Thyroxine / Q000031:analogs & derivatives* / Q000378:metabolism; D014284:Triiodothyronine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology
chemical_list: D001798:Blood Proteins; D011994:Recombinant Proteins; D014284:Triiodothyronine; C010642:3,3',5-triiodothyroacetic acid; D013972:Thyrotropin; C011126:tetraiodothyroacetic acid; D013974:Thyroxine